Product
Supplier
Encyclopedia
Inquiry
Home > Pharmaceutical Intermediates > Bulk Drug Intermediates > Semaglutide for Sale > Samaglutide 99% Fast Delivery Raw Powder Weight Loss Peptide 30mg
Samaglutide 99% Fast Delivery Raw Powder Weight Loss Peptide 30mg buy - large image1
Samaglutide 99% Fast Delivery Raw Powder Weight Loss Peptide 30mg buy - image1
Samaglutide 99% Fast Delivery Raw Powder Weight Loss Peptide 30mg buy - image2
Samaglutide 99% Fast Delivery Raw Powder Weight Loss Peptide 30mg buy - image3
Samaglutide 99% Fast Delivery Raw Powder Weight Loss Peptide 30mg buy - image4
Samaglutide 99% Fast Delivery Raw Powder Weight Loss Peptide 30mg buy - image5
Samaglutide 99% Fast Delivery Raw Powder Weight Loss Peptide 30mg buy - image6

Samaglutide 99% Fast Delivery Raw Powder Weight Loss Peptide 30mg

492 Inquiries

Unit Price:

$50/UNIT FOB

Get Latest Price
CAS No.:

910463-68-2

Grade:

Research Grade

Content:

99%

Port:

深圳

Brand:

Generic

Packaging:

30mg/vial

Price valid (until):

2026-09-24

Company Type:
Trader
Location:
China
Qualification:
Main Products:

Peptides

  • Product Description

  • Seller Information

  • Inquiry History

  • Description


      Product Detail  


    Name:Elare

    Whatsapp:+852 5535 7215

    Please add me for our latest price list and COA


      Product Detail  





    1. Semaglutide 30mg Product Description

      Semaglutide 10mg is a pharmaceutical-related peptide product containing semaglutide as the active ingredient, supplied according to a defined 10mg product specification. The product is intended for qualified professional, pharmaceutical, research, or other authorized applications, subject to applicable laws, regulations, and technical requirements.

      Product Overview

      Semaglutide is a synthetic peptide compound used as an active ingredient in certain pharmaceutical products. Semaglutide 10mg provides a clearly specified quantity of the active ingredient for professional product management and authorized applications.

      The product is supplied according to the applicable specification, with product identity, strength, packaging, labeling, and other relevant information established for the corresponding product batch. The physical appearance and presentation may vary depending on the applicable formulation, packaging configuration, and product specification.

      Manufacturing Process

      Professional production involves controlled procedures covering raw-material management, manufacturing operations, process monitoring, quality inspection, packaging, storage, and batch traceability.

      A standardized production system can include appropriate controls at different stages of manufacturing. Raw materials may be subject to qualification and incoming inspection before use. Production activities are performed according to documented procedures, while relevant process parameters are monitored as applicable.

      Following production, the finished product can undergo quality assessment according to the established specification. Batch records and quality records provide traceability between the production process, testing results, packaging, and finished product.

      Specific manufacturing procedures, equipment, process parameters, and facility qualifications should be verified against the actual production site and applicable documentation rather than assumed from general product descriptions.

      Quality Control

      Quality control is an important part of the production and supply process. Depending on the applicable product specification, quality assessment may include parameters such as:

      • Product identification
      • Active ingredient content
      • Purity
      • Appearance
      • Relevant physicochemical characteristics
      • Batch consistency
      • Packaging integrity
      • Other applicable analytical parameters

      Testing methods and acceptance criteria should be established according to the relevant product specification and applicable quality requirements.

      Where available, batch-specific documentation such as a Certificate of Analysis (COA), product specification, analytical results, or batch information may be provided for professional review. Any analytical value or quality statement should correspond to the actual production batch and supporting documentation.

      Product Specification

      The standard product specification is Semaglutide 10mg. The active ingredient is semaglutide, with a specified quantity of 10mg according to the applicable product presentation.

      Product details may include:

      • Product name: Semaglutide
      • Specification: 10mg
      • Active ingredient: Semaglutide
      • Product category: Pharmaceutical-related peptide product
      • Product form: According to the applicable specification
      • Appearance: According to the actual product presentation
      • Packaging: According to product and transportation requirements
      • Documentation: Subject to actual batch availability

      The exact physical form, appearance, packaging size, labeling format, and storage conditions should be confirmed through the relevant product documentation.

      Product Appearance and Packaging

      The appearance of Semaglutide 10mg depends on its actual product form and packaging configuration. Packaging should be appropriate for the characteristics of the product and the intended storage and transportation conditions.

      Each commercial batch should be appropriately identified to support traceability. Where applicable, labeling information may include product name, specification, batch identification, manufacturing information, storage instructions, and other required information.

      Packaging materials and configurations should comply with applicable requirements for the relevant product category and market. Customers should review the actual packaging specification before procurement or distribution.

      Production Management

      A professional manufacturing system may incorporate documented procedures for supplier management, raw-material qualification, production scheduling, process control, equipment management, sanitation, packaging, warehousing, and finished-product release.

      Production records can be maintained for each batch to support traceability and quality management. Where applicable, deviations, inspections, testing records, and release documentation are managed according to established quality procedures.

      Continuous quality management helps reduce variation between production batches and supports consistent product handling. However, specific quality claims should only be made where supported by valid documentation from the actual manufacturer.

      Batch Traceability

      Batch traceability is an important component of pharmaceutical-related product management. A defined batch identification system can connect raw materials, production records, testing results, packaging records, and finished products.

      For B2B transactions, batch-specific documentation can help customers review the relevant technical characteristics of the supplied material. Customers should use the documentation associated with the actual batch rather than relying solely on general product information.

      Documentation

      Depending on the product and applicable requirements, technical documentation may include:

      • Product specification
      • Certificate of Analysis (COA)
      • Batch identification information
      • Analytical test results
      • Packaging information
      • Storage instructions
      • Safety-related documentation where applicable
      • Other technical documents required for professional evaluation

      The availability of documentation may vary by product, batch, destination market, and commercial requirements. Documentation should accurately reflect the actual product and manufacturing conditions.

      Certifications, regulatory registrations, manufacturing qualifications, laboratory results, or compliance statements should not be represented unless valid supporting documents are available.

      Storage and Handling

      Semaglutide 10mg should be stored and handled according to the conditions specified in the applicable technical documentation. Appropriate storage helps maintain product quality and packaging integrity during the intended storage period.

      Customers should review the product-specific storage instructions before receiving, storing, transporting, processing, or using the product. Temperature, moisture, light exposure, contamination, and other environmental factors should be managed according to the relevant specification.

      Transportation conditions should also be evaluated based on the actual product presentation and applicable requirements. Packaging should remain intact throughout transportation and storage.

      B2B Supply

      Semaglutide 10mg is positioned for professional B2B supply, with emphasis on defined product specifications, quality documentation, production control, batch traceability, and standardized product management.

      For professional customers, product evaluation can be based on the actual specification, analytical documentation, packaging configuration, storage requirements, production information, and applicable regulatory considerations.

      Supply arrangements should be confirmed according to the actual product specification and destination-market requirements. Different countries and regions may apply different rules to pharmaceutical ingredients, peptide products, pharmaceutical-related materials, research materials, and finished dosage forms.

      Customers are responsible for determining whether the intended procurement, importation, distribution, processing, or use complies with the laws and regulations applicable to their market.

      Quality-Oriented Manufacturing

      A quality-oriented production approach focuses on maintaining controlled procedures throughout the product lifecycle. This may include qualified raw-material suppliers, documented production processes, appropriate quality-control procedures, controlled packaging operations, and traceable batch records.

      Manufacturing consistency is supported through process documentation and quality monitoring. Finished-product testing provides additional information for batch evaluation, while appropriate storage and transportation procedures help maintain product integrity after production.

      The actual manufacturing capability and quality system should be evaluated using facility-specific documentation and current records. General descriptions should not be interpreted as confirmation of a specific certification, manufacturing standard, or regulatory status.

      Professional Applications

      Semaglutide 10mg may be supplied for qualified professional, pharmaceutical, research, or other legally authorized applications, depending on the product form and applicable regulations.

      The product should only be handled or used by appropriately qualified organizations or personnel where required by local law. Intended use, regulatory classification, import requirements, labeling requirements, and distribution restrictions may vary between markets.

      No specific medical, therapeutic, diagnostic, or performance claim is made in this product description.

      Regulatory Considerations

      Regulatory requirements for semaglutide-related products can vary by country and region. Requirements may apply to product registration, importation, storage, distribution, labeling, manufacturing, or authorized use.

      Before commercial transactions or product application, customers should independently verify the applicable regulations in the destination market. Product information should be reviewed together with official technical and regulatory documentation.

      Any statement concerning GMP, regulatory approval, certification, registration, pharmaceutical grade, or compliance should be used only when it is supported by current documentation applicable to the actual product and manufacturing facility.

      Product Consistency

      Consistent product specifications are important for professional procurement and downstream quality management. Manufacturing controls, analytical testing, batch records, and appropriate packaging procedures can contribute to reliable product consistency.

      Each batch should be evaluated according to its applicable specification. Differences in production batches, product forms, packaging configurations, or testing requirements should be reflected in the relevant documentation.

      Customers requiring specific technical parameters should refer to the applicable product specification and batch documentation before making purchasing or processing decisions.


    Items Specifications
    Product Name Samaglutide
    Grade Research Grade
    Package 30mg/Vial
    Appearance Lyophilized Powder
    Model Samaglutide 30mg
    Brand Generic

    Shop Retatrutide 15mg High Purity Peptide Research Compound Powder Product-Detailed Image 1

    Shop Retatrutide 15mg High Purity Peptide Research Compound Powder Product-Detailed Image 2
    Shop Retatrutide 15mg High Purity Peptide Research Compound Powder Product-Detailed Image 3
    Shop Retatrutide 15mg High Purity Peptide Research Compound Powder Product-Detailed Image 4
    Shop Retatrutide 15mg High Purity Peptide Research Compound Powder Product-Detailed Image 5
    Shop Retatrutide 15mg High Purity Peptide Research Compound Powder Product-Detailed Image 6
    Shop Retatrutide 15mg High Purity Peptide Research Compound Powder Product-Detailed Image 7
    Shop Retatrutide 15mg High Purity Peptide Research Compound Powder Product-Detailed Image 8
    Shop Retatrutide 15mg High Purity Peptide Research Compound Powder Product-Detailed Image 9
    Shop Retatrutide 15mg High Purity Peptide Research Compound Powder Product-Detailed Image 10
    ECHEMI Editorial Reference
    Semaglutide, a long-acting GLP-1 analogue, is a glucagon-like peptide-1 (GLP-1) receptor agonist that can be used in the treatment of type 2 diabetes.
    Semaglutide(910463-68-2) is an anti-diabetic medication that is sold under brand names such as Ozempic, Wegovy, and Rybelsus. It is used to treat type 2 diabetes and manage chronic weight. The drug functions similar to human glucagon-like peptide-1 (GLP-1) by increasing insulin secretion, which leads to improved sugar metabolism. It is distributed as a metered subcutaneous injection in a prefilled pen, or as an oral form. One of its advantages over other antidiabetic drugs is that it has a long duration of action, thus, only once-a-week injection is sufficient.
    The story of semaglutide began in the 1980s when scientists (such as Joel Habener and Jens Juul Holst) discovered GLP-1, a hormone in the human body that regulates blood sugar and appetite. However, its highly degradable nature limited its potential for medicinal use. In the 1990s, researchers at Novo Nordisk in Denmark, including Lotte Bjerre Knudsen, drew inspiration from the Gila monster's venom protein Exendin-4 and successfully developed the first GLP-1 drug, exenatide. In pursuit of a longer-acting drug, the Novo Nordisk team, led by Knudsen, created a once-daily liraglutide in the 2000s by structurally modifying human GLP-1 and adding fatty acid chains. Building on this success, the team further optimized the formula, ultimately leading to the development of semaglutide, with a longer half-life, by scientists including a research team led by Mads Krogsgaard Thomsen. It was approved in 2017 as a once-weekly blood sugar lowering drug (Ozempic), and in 2021 it shocked the world with its remarkable effects in the field of weight loss (Wegovy), evolving from a scientific concept into a benchmark drug that changes the treatment of metabolic diseases.
    ChEBI: Semaglutide is a polypeptide that contains a linear sequence of 31 amino acids joined together by peptide linkages. It is an agonist of glucagon-like peptide-1 receptors (GLP-1 AR) and used for the treatment of type 2 diabetes. It has a role as a hypoglycemic agent, a glucagon-like peptide-1 receptor agonist, an anti-obesity agent, a neuroprotective agent and an appetite depressant. It is a polypeptide and a lipopeptide.
    Semaglutide Synthetic is a single, non-glycosylated polypeptide chain containing 31 amino acids, having a molecular mass of 4113 Dalton and a Molecular formula of C187H291N45O59.

    Basic Info
    Product Name:

    Semaglutide

    Other Name:

    Sermaglutide;Semaglutide impurity;Sermaglutide USP/EP/BP;semaglutide;Sermaglutide CAS 910463 68 2;Semaglutide (H-7894.0001);semgalutide;Semaglutide Injection

    CAS No.:

    910463-68-2

    Molecular Formula:

    C187H291N45O59

    InChIKeys:

    DLSWIYLPEUIQAV-CCUURXOWSA-N

    Molecular Weight:

    4113.57754

    Exact Mass:

    4113.122087 g/mol

    EC Number:

    203-405-2

    Color/Form:

    White to off-white

    Characteristics
    PSA:

    1650 Ų

    XLogP3:

    5.44520

    Critical Temperature & Pressure:

    Store at -20°C

    Research
    Class:

    GLP-1R agonist

    Status:

    FDA-approved (Ozempic / Wegovy / Rybelsus)

    Mechanism:

    Long-acting, selective glucagon-like peptide-1 (GLP-1) receptor agonist with 94% sequence homology to human GLP-1. Engineered for extended half-life (~1 week) via albumin binding (fatty acid acylation at Lys26) and resistance to DPP-4 degradation (Aib substitution at position 8). Promotes insulin secretion, inhibits glucagon release, delays gastric emptying, and reduces appetite via central nervous system GLP-1R activation.

    Activity note:

    Potent, selective GLP-1R agonist. Reported binding affinity Ki = 0.38 ± 0.06 nM. Semaglutide is a human GLP-1 analog with structural modifications for albumin binding (C18 fatty diacid at Lys26) and enzymatic stability (Aib8 substitution).

    Source:

    Lau J, et al. J Med Chem. 2015;58(18):7370-7380. Wilding JPH, et al. N Engl J Med. 2021;384(11):989-1002.DOI

    Clinical Development:

    NCT03548935; NCT03552757; NCT01720446; NCT02692716

    FDA:

    Ozempic, Wegovy, Rybelsus (approved 2017-12-05)

    References
    ChEMBL:

    CHEMBL2108724

    DrugBank:

    DB13928

    KEGG DRUG:

    D10025

    PubChem:

    PubChem

    Disclaimer:

    Semaglutide is approved as a prescription medicine (Ozempic, Wegovy, Rybelsus) in certain jurisdictions. This listing is for industrial and laboratory research use only. Research-chemical listings on B2B marketplaces are not interchangeable with approved medicines. Confirm CAS, specification, and regulatory pathway with the seller. It is not medical advice, a clinical recommendation, or an approved therapy description.

    Hazard Identification

    Classification of the substance or mixture

    Reproductive toxicity, Category 2

    GHS label elements, including precautionary statements

    Pictogram(s)
    Signal word

    Warning

    Hazard statement(s)

    H361 Suspected of damaging fertility or the unborn child

    Precautionary statement(s)
    Prevention

    P203 Obtain, read and follow all safety instructions before use.

    P280 Wear protective gloves/protective clothing/eye protection/face protection/hearing protection/...

    Response

    P318 IF exposed or concerned, get medical advice.

    Storage

    P405 Store locked up.

    Disposal

    P501 Dispose of contents/container to an appropriate treatment and disposal facility in accordance with applicable laws and regulations, and product characteristics at time of disposal.

    Other hazards which do not result in classification

    no data available

    Handling and Storage

    Precautions for safe handling

    Handling in a well ventilated place. Wear suitable protective clothing. Avoid contact with skin and eyes. Avoid formation of dust and aerosols. Use non-sparking tools. Prevent fire caused by electrostatic discharge steam.

    Conditions for safe storage, including any incompatibilities

    Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials.

  • Seller Information
    Business Type:

    Trader

    Main Products:

    Peptides

    Location:

    Y17, Room 310, East Third Floor, No. 64 and 66 Jianzhong Road, Tianhe District, Guangzhou City

    Payment Terms:

    TT against copy of documents,100% TT in advance

    Average lead Time:

    1

    Total Employees:

    11-50

    Year of Establishment:

    2026

    Founded in 2024, PGpeptides is a specialized supplier of high-purity
    research peptides serving the global scientific community. With deep
    industry expertise, we deliver consistent product quality, competitive
    pricing, and flexible service tailored to research institutions, laboratories,
    and distributors worldwide.
    Our operations span North America, Europe, Asia, Australia, and the
    Middle East, backed by a mature international trade infrastructure and a
    reliable global fulfillment network. We have earned strong recognition 
    and trust across the markets we serve.
  • Inquiry History
    492 Inquiries
    Country Product Purchase Quantity Date Posted
    United States

    Weight Loss Semaglutide intermediate 99% White powder COA High Quality peptide GLP-1 910463-68-2

    5 MG Apr 11, 2024
    United States

    Gene-Biocon Semaglutide 910463-68-2 GLP-1analogs diabetes weight loss 96% White or off-white powder

    Dec 5, 2023
    United States

    Semaglutide 910463-68-2

    1 G Sep 21, 2023
    China

    Semaglutide CAS 910463-68-2

    1 KG Apr 16, 2026
    United States

    Sermaglutide 99% 910463-68-2

    2 KG Oct 21, 2023
    United Kingdom

    TGYFactory Supply Semaglutide Peptide 99% CAS 910463-68-2

    50 MT Nov 13, 2023
    Sri Lanka

    Bulk Supply 98% up Sermaglutide powder CAS 910463-68-2

    300 G Nov 18, 2023
    United States

    Semaglutide Ozempic Sermaglutide 99.9% white powder 910463-68-2 Teruiop

    500 G Oct 9, 2023
    United States

    Raw mateiral Semaglutide CAS 910463-68-2 99% White powder

    1000 G Sep 23, 2023
    United States

    10MG vial pack Semaglutide 99% 910463-68-2 GLP-1 Peptide

    10 MT Oct 18, 2023
    Switzerland

    Semaglutide Ozempic Sermaglutide 99.9% white powder 910463-68-2 Teruiop

    5000 MT Sep 13, 2023
    United States

    High Purity Peptide Semaglutide 910463-68-2 With Safe Shipping

    1 G Sep 7, 2023
    United States

    High Purity IGF-1 LR3 Peptide CAS 910463-68-2 IGF1 LR3

    60 MG Aug 4, 2025
    China

    Semaglutide Tirzepatide for Weight Loss CAS: 910463-68-2 Retatrutide Cagrilintide

    1 MT Jul 5, 2025
    United States

    High Purity IGF-1 LR3 Peptide CAS 910463-68-2 IGF1 LR3

    10 MT Sep 19, 2025
    United States

    High Purity IGF-1 LR3 Peptide CAS 910463-68-2 IGF1 LR3

    Nov 13, 2024
    United States

    semaglutide CAS 910463-68-2 in stock 2-4 days safe delivery

    1 MT Nov 4, 2023
    United Kingdom

    API Pharmaceutical Chemical Grade Raw Materials CAS 910463-68-2 Semaglutide

    40 MT Sep 27, 2023
    United States

    High Purity IGF-1 LR3 Peptide CAS 910463-68-2 IGF1 LR3

    10  Sep 27, 2023
    India

    Best Price 99% Semaglutide Peptide 10mg Vials Semaglutide CAS 910463-68-2

    100  Nov 8, 2023
    Post an enquiry for this product
pic ×

Scan the QR Code to Share

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.